Urologic Surgical Oncology

At Rutgers Cancer Institute, our expert urologic cancer surgeons are committed to providing the most comprehensive, highest-quality, compassionate, and exceptional personalized care tailored to your specific type and stage of genitourinary cancer.

We offer advanced surgical therapies for the diagnosis and treatment of localized and advanced genitourinary cancers.

Surgeon holding model kidneys in gloved palms

Call 844-CANCERNJ (844-226-2376) to schedule an appointment.


Conditions We Treat

Together with RWJBarnabas Health, we specialize in advanced treatments for complex tumors of the brain and spine, offering a full spectrum of care with both minimally invasive and state-of-the-art surgical techniques.

  • Prostate Cancer 
  • Bladder Cancer
  • Kidney Cancer
  • Testicular Cancer
  • Penile Cancer

Explore all Cancer Surgical Services at Rutgers Cancer Institute →


Why Choose Us for Your Urologic Cancer Care?

The Latest Advanced Treatment Options

We offer the latest and most technologically advanced diagnostic and surgical therapies for our patients, including blue light cystoscopy to enhance detection of high-grade bladder cancers, Jelmyto for treating upper urinary tract cancers, single-port and multi-port robotic surgery for treating prostate, kidney, and bladder cancers, image-guided (MRI with ultrasound fusion) diagnosis and treatment of prostate cancer, organ sparing surgeries for patients with kidney cancer, and nerve-sparing surgeries for men with testicular and prostate cancers aimed to preserve fertility and sexual function.

Nationally Recognized Cancer Centers

Our Prostate Cancer program at Rutgers Cancer Institute and Robert Wood Johnson University Hospital has been designated as a high-performing center for prostate cancer surgery by U.S. News & World Report. Our Testicular Cancer Program has been designated a Center of Excellence by the Testicular Cancer Awareness Foundation, which is the leading Testicular Cancer Organization in the United States.

Leaders in Practice and Education

As New Jersey’s only National Cancer Institute (NCI)-Designated Comprehensive Cancer Center, we offer the most exhaustive and innovative genitourinary clinical trial portfolio in the state of New Jersey and are well-versed to treat the most complex and challenging patients with cancers of the prostate, kidney, bladder, ureter, urethra, testicle, and penis. Our urologic cancer surgeons are at the forefront of educating the next generation of leaders in the field and developing novel diagnostic biomarkers and new therapeutics and sequences of therapies aimed to improve the outcome of patients with genitourinary cancers.


Additional Resources


Meet Our Team

Your care team will include a multi-disciplinary team of nationally recognized and highly experienced urologic cancer surgeons, medical oncologists, and radiation oncologists.

Generic Headshot Placeholder

Thomas Jang, MD, MPH, FACS

Chief of Urologic Oncology, Rutgers Cancer Institute

Program Director, Urology Residency Program, Rutgers Robert Wood Johnson Medical School

Professor, Rutgers Robert Wood Johnson Medical School

Generic Headshot Placeholder

Saum Ghodoussipour, MD

Urologic Oncologist

Director of Bladder and Urothelial Cancer Program, Rutgers Cancer Institute

Assistant Professor of Surgery, Rutgers Robert Wood Johnson Medical School

Generic Headshot Placeholder

David M. Golombos, MD

Urologic Oncologist

Associate Professor of Surgery, Rutgers Robert Wood Johnson Medical School

Generic Headshot Placeholder

Vignesh T. Packiam, MD

Director of Clinical and Translational Research in Urologic Oncology

Urologic Oncologist

Generic Headshot Placeholder

Annie Daniel, MSN, DNP, APN-C

Advanced Practice Provider

Generic Headshot Placeholder

Alexa Scholly, MPAS, PA-C

Physician Assistant

Generic Headshot Placeholder

Victorianna Belcastro, APN

Advanced Practice Provider


Related Articles and Press